SEC Info - Corindus Vascular Robotics, Inc. - ‘S-3’ on 4/17/17

SEC Info℠

Home

Help

Please Sign In

Corindus Vascular Robotics, Inc. – ‘S-3’ on 4/17/17 – ‘EX-12.1’

On: Monday, 4/17/17, at 5:17pm ET · Accession #: 1387131-17-2118 · File #: 333-217344

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/17/17  Corindus Vascular Robotics, Inc.  S-3                    7:2.1M                                   Quality EDGAR So… LLC/FA

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement for Securities Offered       HTML    225K 
                          Pursuant to a Transaction                              
 2: EX-4.1      Specimen Stock Certificate                          HTML      5K 
 3: EX-4.2      Form of Senior Indenture                            HTML    214K 
 4: EX-4.3      Form of Subordinated Indenture                      HTML    231K 
 5: EX-5.1      Legal Opinion                                       HTML     40K 
 6: EX-12.1     Computation of Ratio of Earnings to Fixed Charges   HTML     14K 
 7: EX-23.1     Consent of Independent Registered Public            HTML      7K 
                          Accounting Firm

EX-12.1 — Computation of Ratio of Earnings to Fixed Charges

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

CORINDUS VASCULAR ROBOTICS, INC. S-3

Exhibit 12.1

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES⁽¹⁾

The following table sets forth Corindus Vascular Robotics, Inc.’s ratio of earnings to fixed charges for the periods indicated.


	Fiscal year ended December 31,
(dollars in thousands)	2016			2015			2014			2013			2012

Net loss from continuing operations	$	(33,078	)	$	(28,763	)	$	(24,541	)	$	(14,691	)	$	(9,691	)

Fixed charges:

Interest and other expense, net		1,001			1,592			415			—			—

Warrant revaluation								2,421			—			—

Total fixed charges		1,001			1,592			2,836			—			—
Net loss from continuing operations plus fixed charges	$	(32,077	)	$	(27,171	)	$	(21,705	)	$	(14,691	)	$	(9,691	)
Ratio of earnings to fixed charges⁽²⁾		—			—			—			—			—

(1)

The ratio of earnings to fixed charges is defined as earnings divided by fixed charges. For purposes of this ratio, earnings is defined as net loss from continuing operations plus fixed charges. Fixed charges is defined as the sum of interest expense and the component of rental expense that we believe to be representative of the interest factor for those amounts.

(2)

For the years ended December 31, 2012 and 2013 there were no fixed charges. For the years ended December 31, 2014, 2015 and 2016, earnings were insufficient to cover fixed charges by $24,541, $28,763, and $33,078, respectively.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3’ Filing	Date	Other Filings

Filed on:	4/17/17	S-3
	12/31/16	10-K
	12/31/15	10-K, 10-K/A
	12/31/14	10-K
	12/31/13	10-Q
	12/31/12	10-Q
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/26/17  SEC                               UPLOAD¶    10/04/17    1:38K  Corindus Vascular Robotics, Inc.

↑Top

Filing Submission 0001387131-17-002118 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)